Symrise, DE000SYM9999

Symrise stock sets CFO succession for April 2027

Published on 11/12/2026 at 17:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Symrise stock is set for a planned CFO transition as Martin Huber succeeds Olaf Klinger in 2027. Walter Ribeiro will remain on the executive board.

Leadership changes shape Symrise outlook

  • Martin Huber will bring more than 20 years of international finance experience to the CFO role.
  • Olaf Klinger will remain in office through March 31, 2027, supporting an orderly handover.
  • Walter Ribeiro will continue leading Taste, Nutrition & Health through September 19, 2031.
Symrise, DE000SYM9999, Illustration mit AI erstellt.

Symrise announced on November 10 that Martin Huber will become its Chief Financial Officer on April 1, 2027, succeeding Olaf Klinger in a planned transition. The supervisory board also extended Walter Ribeiro's executive board mandate, keeping two important leadership decisions in focus for investors.

Planned handover strengthens continuity

According to Symrise, Huber, 56, brings more than 20 years of international finance and leadership experience from Nestle, Nespresso and Aryzta. The company said he contributed to transformation, profitability, cash flow and return on capital at Aryzta.

Klinger will remain CFO until March 31, 2027, and will leave the executive board after more than eleven years in the role. He said he had not intended to seek another term beyond January 2028, describing the timing as appropriate for preparing the next generation of financial leadership.

Ribeiro mandate extended

Ribeiro, 56, will remain President of Taste, Nutrition & Health under a mandate extended through September 19, 2031. He has served on the executive board since September 2024 and has been with Symrise for more than 30 years.

For investors, the announcement points to continuity in the company's strategic framework while preparing a change in financial leadership. Huber is expected to support the ongoing ONE SYM transformation, disciplined capital allocation and long-term profitable growth. The transition will not take effect until 2027, leaving time for a handover under Klinger.

Symrise AG at a glance

  • Company: Symrise AG
  • ISIN: DE000SYM9999
  • Business: Flavors, fragrances, cosmetic and functional ingredients
  • Leadership event: CFO transition announced November 10, 2026

The DAX provides the broader German equity backdrop for Symrise stock.

More news and analyses on Symrise stock

Disclaimer...
en | DE000SYM9999 | SYMRISE | boerse | 70499910 | bgmi